Primary objective : The primary objective is to evaluate the diagnosis performance of FFOCT for cancer detection in patients undergoing TRUS prostate biopsy, as compared to standard pathological evaluation. Secondary objective: * Evaluate predictive values of FFOCT for cancer detection on prostate biopsy cores * Evaluate the value of FFOCT for cancer characterization on prostate biopsy cores * Evaluate the reproducibility of FFOCT evaluation for cancer detection on prostate biopsy cores * Evaluate the learning curve of FFOCT evaluation on prostate biopsy cores * Evaluate FFOCT procedure time
Research in optical imaging has led to the development of the Full Field Optical Coherence Tomography (FFOCT) technology, which allows to image fresh tissues up to a depth of a few hundreds microns. The system is a microscope coupled with an interferometer. A halogen light source is used to illuminate the tissue specimen and a reference mirror. The light retro diffused by the specimen is combined with the light reflected by the mirror, and the interference signal is measured. Multiple Grey scale images are obtained and automatically stitched to obtain a complete slide throughout the specimen. The feasibility of the technique has been reported in various pilot studies, as well as the absence of any potential tissue harm and subsequent pathological artifact caused by the process. FFOCT could be used as an additional detection tool for prostate cancer screening. The use of extended systematic trans-rectal ultrasound-guided (TRUS) prostate biopsies has led to over-diagnosis and over-treatment. Also, the number of unnecessary biopsies has increased, along with the morbidity of the procedure. Performing a "pre-pathological" evaluation of biopsy cores during the biopsy procedure would be of significant help to determine the nature of targeted areas and guide the number of biopsies to perform. We hypothesize that FFOCT imaging of prostate biopsy cores would allow a cancer detection rate not statistically different from pathological analysis.
Study Type
OBSERVATIONAL
Enrollment
91
TRUS Prostate biopsy are performed under the care procedure Pathological examination of these prostate biopsy with FFOCT procedure, as compared to standard pathological evaluation
Assistance Publique - Hôpitaux de Paris Cochin Hospital
Paris, France
To evaluate the diagnosis performance of FFOCT for cancer detection in patients undergoing TRUS prostate biopsy, as compared to standard pathological evaluation
Presence or absence of prostate cancer on pathological examination of prostate biopsy cores
Time frame: One day (biopsy procedure)
To evaluate the predictive values of FFOCT for cancer detection on prostate TRUS biopsy
the positive and negative predictive values for the presence of cancer, based on the prevalence of cancer in the population studied
Time frame: One day (biopsy procedure)
To evaluate the value of FFOCT for cancer characterization on prostate biopsy cores
Gleason score and cancer length of prostate cancer on pathological examination of each prostate biopsy cores
Time frame: One day (biopsy procedure)
To evaluate the reproducibility of FFOCT evaluation for cancer detection on prostate biopsy cores
the inter observer agreement for the diagnosis of cancer between 2 experienced pathologists fully trained to the technique, as well as 2 experienced urologists trained to the technique
Time frame: One day (biopsy procedure)
To evaluate the learning curve of FFOCT evaluation on prostate biopsy cores
the evolution of the diagnostic performance with time when FFOCT images are evaluated with an experienced pathologist untrained to the technique before the beginning of the study
Time frame: One day (biopsy procedure)
To evaluate FFOCT procedure time
the duration of FFOCT procedure
Time frame: One day (biopsy procedure)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.